Merck & Company Inc (MRK) Stock Forecast
US · Healthcare
Current price
$125.45
Market cap
$309.84B
Mean price target
$130.39
Implied upside
3.9%
Key takeaways
- Analysts rate Merck & Company Inc a “Buy”, with a mean price target of $130.39 — about 3.9% upside from the current $125.45, based on 28 analysts.
- MRK is trading near its 52-week high, at 99% of the $76.66–$125.96 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 28 |
| Mean target | $130.39 |
| High target | $150.00 |
| Low target | $100.00 |
| Rating split (SB / B / H / S / SS) | 4 / 14 / 11 / 0 / 0 |
Price & trading
| Current price | $125.45 |
|---|---|
| Previous close | $120.60 |
| 52-week high | $125.96 |
| 52-week low | $76.66 |
| 50-day average | $115.51 |
| Beta | 0.22 |
See the full MRK breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Merck & Company Inc (MRK) share price?
- Merck & Company Inc last traded at $125.45 with a market capitalisation of about $309.8B.
- What is the analyst price target for MRK?
- The mean analyst price target for Merck & Company Inc is $130.39, roughly 3.9% above the latest price. The current consensus rating is “Buy”.
- Where can I see Merck & Company Inc's full financial metrics?
- Luminoso tracks MRK's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.